{"id":385295,"date":"2020-11-19T10:20:10","date_gmt":"2020-11-19T15:20:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=385295"},"modified":"2020-11-19T10:20:10","modified_gmt":"2020-11-19T15:20:10","slug":"biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/","title":{"rendered":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Nov.  19, 2020  (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the \u201cClass Period\u201d).<\/p>\n<p>To join the class action, go to\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4aaoRTenMR_6u67FmbX5A72lHCmKfJcu9VzlVCHPYNQ9KffQTSEBRs5wvBp8WrM5BgBsmUFnHbeZLfHkmNAGWKaZl7NTx8nzaa7pIer15wbdpjlRkJl38C_POiNnT7PdKLcVlU9AahLOC_PRDyrvD6nTzVKmZH-KDQQu6ChIgeLN8lWn06mWmFWMeWnjLIZVX1LiYEN43ZLXPkdStDaxLxn2kXw1G2D0cj-X63z816Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484<\/a> or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fUvN2OBoAi1s7iNiW8TMdtiI_6Ne23Vr72sW_6edzhe3Mk8hqR4_Z-MIV__HT5SCazSANs3mD5UQQIJ21xIhh7CghQN5MZmMalOYqkMQt90=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a>\u00a0for information on the class action.<\/p>\n<p>\u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4aaoRTenMR_6u67FmbX5A72lHCmKfJcu9VzlVCHPYNQ9KffQTSEBRs5wvBp8WrM5BgBsmUFnHbeZLfHkmNAGWKaZl7NTx8nzaa7pIer15wZcHbZUvGg48MQ7U-P5WJuQSHcMF3JO6oFQ0IVAjENstsgXdHYuff9hfXu0Q_g5mXL19ZwWWdDKon0r9O64J8xS3OZzD_r-jaxsFstncEmDOypk0E8Mu9liPijTbQpVc6g=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484<\/a>.<\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>January 12<\/strong><strong>, 20<\/strong><strong>2<\/strong><strong>1<\/strong><strong> DEADLINE<\/strong><strong>.<\/strong>\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0<\/p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: the larger dataset did not provide necessary data regarding aducanumab\u2019s effectiveness; the EMERGE study did not and would not provide necessary data regarding aducanumab\u2019s effectiveness; the PRIME study did not and would not provide necessary data regarding aducanumab\u2019s effectiveness; the data provided by the Company to the FDA\u2019s Peripheral and Central Nervous System Drugs Advisory Committee did not support finding efficacy of aducanumab; and as a result, defendants\u2019 statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n<p>Lead plaintiff status is not required to seek compensation.\u00a0 You may retain counsel of your choice.\u00a0 You may remain an absent class member and take no action at this time.<\/p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>Zhang Investor Law P.C.<br \/>99 Wall Street, Suite 232<br \/>New York, New York 10005<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fUvN2OBoAi1s7iNiW8TMdtiI_6Ne23Vr72sW_6edzhcUgTqTNG7N7CFyx4TZskl8LDdq2fk8q9nKWitdD6derh-uoUMU4Pqzt0rURzcvS4M=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@zhanginvestorlaw.com<\/a><br \/>tel: (800) 991-3756<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/cff7f77c-31cd-434b-8939-1d197892a411\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484. If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-385295","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484. If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: the &hellip; Continue reading &quot;BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T15:20:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB\",\"datePublished\":\"2020-11-19T15:20:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/\",\"name\":\"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\",\"datePublished\":\"2020-11-19T15:20:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/","og_locale":"en_US","og_type":"article","og_title":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk","og_description":"NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) &#8212; Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Biogen Inc. (NASDAQ: BIIB) between October 22, 2019 and November 6, 2020, inclusive (the \u201cClass Period\u201d). To join the class action, go to\u00a0http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email\u00a0info@zhanginvestorlaw.com\u00a0for information on the class action. \u5982\u679c\u60a8\u60f3\u52a0\u5165\u8fd9\u4e2a\u96c6\u4f53\u8bc9\u8bbc\u6848\uff0c\u8bf7\u5728\u8fd9\u91cc\u63d0\u4ea4\u60a8\u7684\u4fe1\u606f\u3002http:\/\/zhanginvestorlaw.com\/join-action-form\/?slug=biogen-inc&amp;id=2484. If you wish to serve as lead plaintiff, you must move the Court before the January 12, 2021 DEADLINE.\u00a0\u00a0 A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.\u00a0 According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: the &hellip; Continue reading \"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-19T15:20:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB","datePublished":"2020-11-19T15:20:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/"},"wordCount":318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/","name":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==","datePublished":"2020-11-19T15:20:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4OTMyNSMzODM2MDI1IzUwMDA1MzY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biib-stock-alert-zhang-investor-law-announces-securities-class-action-lawsuit-against-biogen-inc-biib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BIIB STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Biogen Inc. \u2013 BIIB"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=385295"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/385295\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=385295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=385295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=385295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}